Scientific documentation is central to Arla Foods Ingredients’ Early life nutrition ingredient portfolio. We are committed to deliver safety and efficacy evidence of our ingredients for the infant formula industry by providing our customers highly developed and targeted pre-clinical and clinical evidence that can be integrated into their final product documentation.
Over the years, we’ve built a reputation for solid, evidence-based clinical research in the industry. This work is carried out in close collaboration with leading research partners to provide a solid understanding of the role and mechanism of our ingredients developed for early life nutrition.
Close attention to this aspect is an unwavering principle that has guided our development efforts and documentation investments for decades. At Arla Foods Ingredients, the Pediatric department is on a journey to discover and deliver science based ingredients that support early life nutrition.
Arla Foods Ingredients’ partnerships applies to market insights as well as our sales and marketing experts can contribute valuable industry and consumer insights to support product positioning efforts and accelerate time-to-market.
Science & Insights
2019 highlighted Arla Foods Ingredients’ collaboration studies
The Impact of Immune Interventions: A Systems Biology Strategy for Predicting Adverse and Beneficial Immune Effects.
Click here to learn more.
Preclinical Brown Norway Rat Models for the Assessment of Infant Formulas in the Prevention and Treatment of Cow’s Milk Allergy.
Click here to learn more.